EGFR-targeted therapies combined with chemotherapy for treating advanced non-small-cell lung cancer: a meta-analysis (Q83130974)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21207017%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

meta-analysis

0 references

title

EGFR-targeted therapies combined with chemotherapy for treating advanced non-small-cell lung cancer: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21207017%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

1 reference

Peng Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21207017%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Long Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21207017%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Bing Liu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21207017%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Hai-Zhong Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21207017%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Hong-Chen Liu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21207017%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Zui Zou

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21207017%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

5 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21207017%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21207017%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21207017%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21207017%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

235-243

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21207017%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00228-010-0965-4

19 January 2020

exact match

0 references

cites work

Preclinical studies with Erlotinib (Tarceva).

1 reference

12 December 2020

Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1.

1 reference

12 December 2020

Cetuximab-based therapy versus non-cetuximab therapy for advanced cancer: a meta-analysis of 17 randomized controlled trials

1 reference

12 December 2020

TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.

1 reference

12 December 2020

The safety and efficacy of gefitinib versus platinum-based doublets chemotherapy as the first-line treatment for advanced non-small-cell lung cancer patients in East Asia: a meta-analysis

1 reference

12 December 2020

Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of r

1 reference

12 December 2020

Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer.

1 reference

12 December 2020

Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer

1 reference

12 December 2020

Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial

1 reference

12 December 2020

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

12 December 2020

The epidermal growth factor receptor: a new target for anticancer therapy

1 reference

12 December 2020

Randomized phase II study of gemcitabine plus cisplatin or carboplatin [corrected], with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer

1 reference

12 December 2020

Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2.

1 reference

12 December 2020

Combining the anti-EGFR agent gefitinib with chemotherapy in non-small-cell lung cancer: how do we go from INTACT to impact?

1 reference

12 December 2020

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.

1 reference

12 December 2020

The characterization of gefitinib sensitivity and adverse events in patients with non-small cell lung cancer.

1 reference

12 December 2020

Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments

1 reference

12 December 2020

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

12 December 2020

Erlotinib-induced skin rash. Pathogenesis, clinical significance and management in pancreatic cancer patients

1 reference

12 December 2020

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship

1 reference

12 December 2020

Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer.

1 reference

12 December 2020

Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099.

1 reference

12 December 2020

Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature

1 reference

12 December 2020

Angiotensin receptor blockers and risk of myocardial infarction: systematic review.

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

12 December 2020

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

12 December 2020

Current treatments for advanced stage non-small cell lung cancer

1 reference

12 December 2020

Safety and efficacy of gefitinib treatment in elderly patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience

1 reference

12 December 2020

Inhibition of the epidermal growth factor receptor tyrosine kinase by PD153035 in human A431 tumors in athymic nude mice

1 reference

12 December 2020